Rivastigmine Tartrate

Product NDC
63739-576
11-digit product format
637390576
Labeler code
63739
Product ID
63739-576_b95a67d2-99f6-4b82-e053-2995a90a67a2
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Rivastigmine Tartrate
Dosage form
CAPSULE
Route
ORAL
Labeler
McKesson Corporation dba SKY Packaging
Application
ANDA077129
Marketing category
ANDA
Marketing start
2010-07-01
Marketing end
0000-00-00
Substance
RIVASTIGMINE TARTRATE
Active strength
2 mg/1
Pharmacologic classes
Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
NDC exclude flag
No
Listing certified through
2022-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
63739-576-102020-07-22C16284748780-1ab0e2407-2d5a-f274-e053-dbdaa90a64718dc97a13-c5eb-4421-ae86-7e0877186e2d

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
63739-576-10EA - Each63739-5768007ea05-a833-4017-8a2b-a2f86db86ebb12013-03-03